(Q28275482)

4

0 references

0 references

Nikos Evangelou

7

1 reference

ORCID Public Data File 2021

Chris Polman

5

object named as

Chris H Polman

0 references

author name string

Lars Bø

2

0 references

Omar Al-Rawashdeh

3

0 references

James S Lowe

Multiple Sclerosis Journal

6

0 references

language of work or name

English

0 references

publication date

April 2010

0 references

published in

0 references

volume

16

0 references

page(s)

406-11

0 references

issue

4

0 references

cites work

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Primary progressive multiple sclerosis: a 5-year clinical and MR study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Imaging axonal damage of normal-appearing white matter in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Modelling of multiple sclerosis: lessons learned in a non-human primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Axonal damage in acute multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

The longstanding MS lesion. A quantitative MRI and electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Acquired channelopathies in nerve injury and MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Mitochondrial changes within axons in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Spinal Cord Atrophy in Multiple Sclerosis Caused by White Matter Volume Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Can the Expanded Disability Status Scale be assessed by telephone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

Chemical pathology of acute demyelinating lesions and its correlation with disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992

The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510364992